European Archives - Page 402 of 1589 - European Medical Journal

Atopic Dermatitis Severity Predicted by Flare Patterns

The study examined flare patterns reported in 2022 and correlated them with patient-reported severity measures recorded in 2023.

Infection Risk in Focus: How Do Haematologic Malignancies and Treatments Increase Infection Susceptibility?

Patients with hematologic malignancies are at increased risk of infections, driven by both disease-related immune dysfunction and the…

Heart Disease Mortality Falls as Other Cardiac Deaths Climb in US Study

US heart deaths have dropped since 1970, but deaths from heart failure and arrhythmias are on the rise.

Gecko-Inspired Nanoparticles Revolutionise Bladder Cancer Treatment

A new study offers an innovative solution inspired by nature: soft dendritic particles (SDPs) that mimic the adhesive properties of gecko feet.

Dr Joana Reis, Bayer

Bayer's Dr Joana Reis on the promise of AI in breast cancer

Dr Joana Reis, Medical Affairs Breast Lead, Radiology, Bayer, explores some of the most significant challenges and opportunities in radiology today.

Complement Inhibitors Could Treat Lung Injury in Sickle Cell Disease

Acute chest syndrome (ACS), a life-threatening complication of sickle cell disease (SCD), may be driven by overactivation of the complement system, according to new research.

Diffusion MRI Predicts Breast Cancer Response Early in Chemotherapy

A recent prospective study has directly compared different diffusion MRI parameters over the course of NAC to assess their ability to predict pathologic complete response.

Can Smart Speakers Detect Parkinson’s Early with AI Voice Analysis?

Home voice assistants could help screen for Parkinson’s with AI, heralding accessible, early detection outside clinical environments.

Interview: Catherine Nelson-Piercy

I actually never wanted to be an obstetrician or gynaecologist. I always wanted to be a physician. I was training in diabetes and…

Could psychedelic medicine solve the mental health crisis?

Explore the evolving role of MDMA, LSD and psilocybin in traditional medical research, particularly in the realm of mental health.